To view journal scope & editors or submit a manuscript, please select a specific journal:
With Clinical Lymphoma & Myeloma, CIG Media Group has always sought to evolve along with the interests of its readership. Since the peer-reviewed journal’s debut as Clinical Lymphoma, we have striven to provide physicians and healthcare professionals with the information needed to effectively combat hematologic malignancies. It is this mission that originally led us to expand our scope to include myeloma, and that same mission has led us to broaden our focus a second time.
Therefore, as we work to meet the growing demand from our readership, we are including leukemia content. Beginning with our tenth volume, the journal will be officially titled Clinical Lymphoma, Myeloma & Leukemia.
We welcome Dr. Jorge E. Cortés as our Editor-in-Chief for leukemia content and Drs. Morton Coleman, Raymond L. Comenzo, Guillermo Garcia-Manero, Jeffrey Lancet, and Steven P. Treon as additions to our team of Associate Editors.
We look forward to working closely with our editorial board and our readership to ensure that Clinical Lymphoma, Myeloma & Leukemia remains clinically relevant and promotes our mission.
About Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia includes original articles describing various aspects of clinical and translational research of hematologic malignancies. The journal is devoted to articles on the detection, diagnosis, and treatment of lymphoma, myeloma, leukemia, and related disorders, including macroglobulinemia, amyloidosis, and plasma cell dyscrasias. We welcome original studies, reviews, perspectives, and current trials on these topics.